← Case Library

Clause 6.2

⚖ 27 PMCPA cases 🔒 Members see all 27 cases

PMCPA Cases — Clause 6.2

27 cases
📅 8 Mar 2026 · Roche Products

Roche Resources website: illegible generic name and misleading Ocrevus dosing cadence (AUTH/3541/7/21)

Clause 12.3 Clause 6.1 Clause 6.2
📅 8 Mar 2026 · Daiichi-Sankyo UK

Daiichi-Sankyo: ‘Add on’ cholesterol ad misleading due to simvastatin contraindication buried in footnote (AUTH/3542/7/21)

Clause 2 Clause 5.1 Clause 6.1 Clause 6.2
📅 8 Mar 2026 · Galapagos Biotech

AUTH/3582/11/21: AbbVie v Galapagos — Jyseleca website claims (safety ‘low rates’ and ‘sustained efficacy’ summary)

Clause 5.1 Clause 6.1 Clause 6.2
🔒

See all 27 cases for Clause 6.2

Case Library members get full access to every PMCPA ruling, searchable by clause, company, outcome, and sanction.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

Already a member? Sign in

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free